MaveMD: A functional data resource for genomic medicine
Open accessAbstract
Variants of uncertain significance (VUS) undermine genetic medicine implementation because they have an unknown relationship to disease and cannot be used for clinical decision-making. While evidence from multiplexed assays of variant effect (MAVEs) can help resolve VUS, major barriers prevent routine clinical use, including data fragmentation and assay calibration. To address these challenges, we present MaveMD (MAVEs for MeDicine), a new interface for the MaveDB database that displays clinical evidence calibrations, provides intuitive visualizations, integrates with ClinVar and ClinGen, and exports clinical evidence compatible with ACMG/AMP guidelines. MaveMD currently contains 476,076 variant effect measurements curated from 82 MAVE datasets spanning 39 disease-associated genes, enabling classification of 75% of ClinVar VUS and 62% of future variants in these genes. MaveMD is designed to support and facilitate future data generation efforts and the use of MAVE evidence in clinical practice, thereby reducing the VUS burden and improving genetic medicine outcomes.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
MaveDB has recently been developed further for translational purposes with the release of a clinical layer, MaveMD, which transforms MAVE functional scores into calibrated ACMG-compatible evidence that clinicians can use to support variant classification.
“MaveDB has recently been developed further for translational purposes with the release of a clinical layer of the database – MaveMD – which transforms MAVE functional scores into calibrated ACMG-compatible evidence that clinicians can use to support variant classification (104).”
From Massively parallel functional genomic assays in endocrinology: from promise to delivery (2026) · cites this paper as [104]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594 · see citing works
Flagged first, then by citations
Research works printed but not linked: 80
- Adamovich A.I., Diabate M., Banerjee T., Nagy G., Smith N., Duncan K., Mendoza Mendoza E., Prida G., Freitas M.A., Starita L.M., Parvin J.D., 2022. The functional impact of BRCA1 BRCT domain variants using multiplexed DNA double-strand break repair assays. Am J Hum Genet 109, 618– 630. 10.1016/j.ajhg.2022.01.019 35196514 PMC9069074 · DOI
- Allen S., Garrett A., Rowlands C.F., Durkie M., Burghel G.J., Robinson R., Callaway A., Field J., Frugtniet B., Palmer-Smith S., Grant J., Pagan J., McDevitt T., Snape K., Hanson H., McVeigh T., Adams D.J., Findlay G.M., Villani R.M., Spurdle A.B., Turnbull C., CanVIG-UK Consortium, 2025. Validating data from multiplex assays of variant effect: A CanVIG-UK national survey of NHS clinical scientists. Am J Hum Genet 112, 1479– 1488. 10.1016/j.ajhg.2025.04.006 40480200 PMC12256791 · DOI
- Arbesfeld J.A., Da E.Y., Stevenson J.S., Kuzma K., Paul A., Farris T., Capodanno B.J., Grindstaff S.B., Riehle K., Saraiva-Agostinho N., Safer J.F., Casper J., Haeussler M., Milosavljevic A., Foreman J., Firth H.V., Hunt S.E., Iqbal S., Cline M.S., Rubin A.F., Wagner A.H., 2025. Mapping MAVE data for use in human genomics applications. Genome Biol 26, 179. 10.1186/s13059-025-03647-x 40563119 PMC12188674 · DOI
- Boettcher S., Miller P.G., Sharma R., McConkey M., Leventhal M., Krivtsov A.V., Giacomelli A.O., Wong W., Kim J., Chao S., Kurppa K.J., Yang X., Milenkowic K., Piccioni F., Root D.E., Rücker F.G., Flamand Y., Neuberg D., Lindsley R.C., Jänne P.A., Hahn W.C., Jacks T., Döhner H., Armstrong S.A., Ebert B.L., 2019. A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies. Science 365, 599– 604. 10.1126/science.aax3649 31395785 PMC7327437 · DOI · Paper page
- Bolognesi B., Faure A.J., Seuma M., Schmiedel J.M., Tartaglia G.G., Lehner B., 2019. The mutational landscape of a prion-like domain. Nat Commun 10, 4162. 10.1038/s41467-019-12101-z 31519910 PMC6744496 · DOI
- Briney K.A., 2024. Measuring data rot: An analysis of the continued availability of shared data from a Single University. PLoS One 19, e0304781. 10.1371/journal.pone.0304781 38838010 PMC11152257 · DOI
- Brnich S.E., Abou Tayoun A.N., Couch F.J., Cutting G.R., Greenblatt M.S., Heinen C.D., Kanavy D.M., Luo X., McNulty S.M., Starita L.M., Tavtigian S.V., Wright M.W., Harrison S.M., Biesecker L.G., Berg J.S., Abou Tayoun A.N., Berg J.S., Biesecker L.G., Brenner S.E., Cutting G.R., Ellard S., Greenblatt M.S., Harrison S.M., Karbassi I., Karchin R., Mester J.L., O’Donnell-Luria A., Pesaran T., Plon S.E., Rehm H., Tavtigian S.V., Topper S., On behalf of the Clinical Genome Resource Sequence Variant Interpretation Working Group, 2019. Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework. Genome Medicine 12, 3. 10.1186/s13073-019-0690-2 31892348 PMC6938631 · DOI
- Buckley M., Terwagne C., Ganner A., Cubitt L., Brewer R., Kim D.-K., Kajba C.M., Forrester N., Dace P., De Jonghe J., Shepherd S.T.C., Sawyer C., McEwen M., Diederichs S., Neumann-Haefelin E., Turajlic S., Ivakine E.A., Findlay G.M., 2024. Saturation genome editing maps the functional spectrum of pathogenic VHL alleles. Nat Genet 56, 1446– 1455. 10.1038/s41588-024-01800-z 38969834 PMC11250436 · DOI · Paper page
- Calhoun J.D., Dawood M., Rowlands C.F., Fayer S., Radford E.J., McEwen A.E., Turnbull C., Spurdle A.B., Starita L.M., Jagannathan S., 2025. Combining multiplexed functional data to improve variant classification. ArXiv arXiv:2503.18810v1. PMC13644118 42432739 · arXiv
- Chen E., Facio F.M., Aradhya K.W., Rojahn S., Hatchell K.E., Aguilar S., Ouyang K., Saitta S., Hanson-Kwan A.K., Capurro N.N., Takamine E., Jamuar S.S., McKnight D., Johnson B., Aradhya S., 2023. Rates and Classification of Variants of Uncertain Significance in Hereditary Disease Genetic Testing. JAMA Netw Open 6, e2339571. 10.1001/jamanetworkopen.2023.39571 37878314 PMC10600581 · DOI
- Chen S., Francioli L.C., Goodrich J.K., Collins R.L., Kanai M., Wang Q., Alföldi J., Watts N.A., Vittal C., Gauthier L.D., Poterba T., Wilson M.W., Tarasova Y., Phu W., Grant R., Yohannes M.T., Koenig Z., Farjoun Y., Banks E., Donnelly S., Gabriel S., Gupta N., Ferriera S., Tolonen C., Novod S., Bergelson L., Roazen D., Ruano-Rubio V., Covarrubias M., Llanwarne C., Petrillo N., Wade G., Jeandet T., Munshi R., Tibbetts K., O’Donnell-Luria A., Solomonson M., Seed C., Martin A.R., Talkowski M.E., Rehm H.L., Daly M.J., Tiao G., Neale B.M., MacArthur D.G., Karczewski K.J., 2024. A genomic mutational constraint map using variation in 76,156 human genomes. Nature 625, 92– 100. 10.1038/s41586-023-06045-0 38057664 PMC11629659 · DOI · Paper page
- Chrysafi P., Jani C.T., Lotz M., Al Omari O., Singh H., Stafford K., Agarwal L., Rupal A., Dar A.Q., Dangelo A., Lam P., 2023. Prevalence of Variants of Uncertain Significance in Patients Undergoing Genetic Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome. Cancers (Basel) 15, 5762. 10.3390/cancers15245762 38136308 PMC10742236 · DOI
- Claussnitzer M., Parikh V.N., Wagner A.H., Arbesfeld J.A., Bult C.J., Firth H.V., Muffley L.A., Nguyen Ba A.N., Riehle K., Roth F.P., Tabet D., Bolognesi B., Glazer A.M., Rubin A.F., 2024. Minimum information and guidelines for reporting a multiplexed assay of variant effect. Genome Biol 25, 100. 10.1186/s13059-024-03223-9 38641812 PMC11027375 · DOI
- Costa M., García S A., Pastor O., 2023. The consequences of data dispersion in genomics: a comparative analysis of data sources for precision medicine. BMC Med Inform Decis Mak 23, 256. 10.1186/s12911-023-02342-w 37946154 PMC10636939 · DOI
- Dawood M., Fayer S., Pendyala S., Post M., Kalra D., Patterson K., Venner E., Muffley L.A., Fowler D.M., Rubin A.F., Posey J.E., Plon S.E., Lupski J.R., Gibbs R.A., Starita L.M., Robles-Espinoza C.D., Coyote-Maestas W., Gallego Romero I., 2024. Using multiplexed functional data to reduce variant classification inequities in underrepresented populations. Genome Med 16, 143. 10.1186/s13073-024-01392-7 39627863 PMC11616159 · DOI · Paper page
- den Dunnen J.T., Dalgleish R., Maglott D.R., Hart R.K., Greenblatt M.S., McGowan-Jordan J., Roux A.-F., Smith T., Antonarakis S.E., Taschner P.E.M., 2016. HGVS Recommendations for the Description of Sequence Variants: 2016 Update. Human Mutation 37, 564– 569. 10.1002/humu.22981 26931183 · DOI
- DiStefano M.T., Goehringer S., Babb L., Alkuraya F.S., Amberger J., Amin M., Austin-Tse C., Balzotti M., Berg J.S., Birney E., Bocchini C., Bruford E.A., Coffey A.J., Collins H., Cunningham F., Daugherty L.C., Einhorn Y., Firth H.V., Fitzpatrick D.R., Foulger R.E., Goldstein J., Hamosh A., Hurles M.R., Leigh S.E., Leong I.U.S., Maddirevula S., Martin C.L., McDonagh E.M., Olry A., Puzriakova A., Radtke K., Ramos E.M., Rath A., Riggs E.R., Roberts A.M., Rodwell C., Snow C., Stark Z., Tahiliani J., Tweedie S., Ware J.S., Weller P., Williams E., Wright C.F., Yates T.M., Rehm H.L., 2022. The Gene Curation Coalition: A global effort to harmonize gene–disease evidence resources. Genetics in Medicine 24, 1732– 1742. 10.1016/j.gim.2022.04.017 35507016 PMC7613247 · DOI
- Esposito D., Weile J., Shendure J., Starita L.M., Papenfuss A.T., Roth F.P., Fowler D.M., Rubin A.F., 2019. MaveDB: an open-source platform to distribute and interpret data from multiplexed assays of variant effect. Genome Biology 20, 223. 10.1186/s13059-019-1845-6 31679514 PMC6827219 · DOI
- Fayer S., Horton C., Dines J.N., Rubin A.F., Richardson M.E., McGoldrick K., Hernandez F., Pesaran T., Karam R., Shirts B.H., Fowler D.M., Starita L.M., 2021. Closing the gap: Systematic integration of multiplexed functional data resolves variants of uncertain significance in BRCA1, TP53, and PTEN. Am J Hum Genet 108, 2248– 2258. 10.1016/j.ajhg.2021.11.001 34793697 PMC8715144 · DOI
- Federer L.M., 2022. Long-term availability of data associated with articles in PLOS ONE. PLoS One 17, e0272845. 10.1371/journal.pone.0272845 36001577 PMC9401135 · DOI
- Findlay G.M., 2021. Linking genome variants to disease: scalable approaches to test the functional impact of human mutations. Hum Mol Genet 30, R187– R197. 10.1093/hmg/ddab219 34338757 PMC8490018 · DOI
- Findlay G.M., Daza R.M., Martin B., Zhang M.D., Leith A.P., Gasperini M., Janizek J.D., Huang X., Starita L.M., Shendure J., 2018. Accurate classification of BRCA1 variants with saturation genome editing. Nature 562, 217– 222. 10.1038/s41586-018-0461-z 30209399 PMC6181777 · DOI · Paper page
- Fortuno C., Pesaran T., Dolinsky J., Yussuf A., McGoldrick K., Tavtigian S.V., Goldgar D., Spurdle A.B., James P.A., 2021. An updated quantitative model to classify missense variants in the TP53 gene: A novel multifactorial strategy. Hum Mutat 42, 1351– 1361. 10.1002/humu.24264 34273903 · DOI
- Fowler D.M., Fields S., 2014. Deep mutational scanning: a new style of protein science. Nat Meth 11, 801– 807. 10.1038/nmeth.3027 PMC4410700 25075907 · DOI · Paper page
- Gebbia M., Zimmerman D., Jiang R., Nguyen M., Weile J., Li R., Gavac M., Kishore N., Sun S., Boonen R.A., Hamilton R., Dines J.N., Wahl A., Reuter J., Johnson B., Fowler D.M., Couch F.J., van Attikum H., Roth F.P., 2024. A missense variant effect map for the human tumor-suppressor protein CHK2. Am J Hum Genet 111, 2675– 2692. 10.1016/j.ajhg.2024.10.013 39642869 PMC11639082 · DOI
- Gersing S., Cagiada M., Gebbia M., Gjesing A.P., Coté A.G., Seesankar G., Li R., Tabet D., Weile J., Stein A., Gloyn A.L., Hansen T., Roth F.P., Lindorff-Larsen K., Hartmann-Petersen R., 2023. A comprehensive map of human glucokinase variant activity. Genome Biol 24, 97. 10.1186/s13059-023-02935-8 37101203 PMC10131484 · DOI · Paper page
- Gersing S., Schulze T.K., Cagiada M., Stein A., Roth F.P., Lindorff-Larsen K., Hartmann-Petersen R., 2024. Characterizing glucokinase variant mechanisms using a multiplexed abundance assay. Genome Biol 25, 98. 10.1186/s13059-024-03238-2 38627865 PMC11021015 · DOI · Paper page
- Giacomelli A.O., Yang X., Lintner R.E., McFarland J.M., Duby M., Kim J., Howard T.P., Takeda D.Y., Ly S.H., Kim E., Gannon H.S., Hurhula B., Sharpe T., Goodale A., Fritchman B., Steelman S., Vazquez F., Tsherniak A., Aguirre A.J., Doench J.G., Piccioni F., Roberts C.W.M., Meyerson M., Getz G., Johannessen C.M., Root D.E., Hahn W.C., 2018. Mutational processes shape the landscape of TP53 mutations in human cancer. Nature Genetics 1. 10.1038/s41588-018-0204-y PMC6168352 30224644 · DOI · Paper page
- Gilbert M.A., Keefer-Jacques E., Jadhav T., Antfolk D., Ming Q., Valente N., Shaw G.T.-W., Sottolano C.J., Matwijec G., Luca V.C., Loomes K.M., Rajagopalan R., Hayeck T.J., Spinner N.B., 2024. Functional characterization of 2,832 JAG1 variants supports reclassification for Alagille syndrome and improves guidance for clinical variant interpretation. Am J Hum Genet 111, 1656– 1672. 10.1016/j.ajhg.2024.06.011 39043182 PMC11339624 · DOI
- Glazer A.M., Kroncke B.M., Matreyek K.A., Yang T., Wada Y., Shields T., Salem J.-E., Fowler D.M., Roden D.M., 2020. Deep Mutational Scan of an SCN5A Voltage Sensor. Circ Genom Precis Med 13, e002786. 10.1161/CIRCGEN.119.002786 31928070 PMC7031040 · DOI
- Grønbæk-Thygesen M., Voutsinos V., Johansson K.E., Schulze T.K., Cagiada M., Pedersen L., Clausen L., Nariya S., Powell R.L., Stein A., Fowler D.M., Lindorff-Larsen K., Hartmann-Petersen R., 2024. Deep mutational scanning reveals a correlation between degradation and toxicity of thousands of aspartoacylase variants. Nat Commun 15, 4026. 10.1038/s41467-024-48481-0 38740822 PMC11091098 · DOI
- Hart R.K., Prlić A., 2020. SeqRepo: A system for managing local collections of biological sequences. PLoS One 15, e0239883. 10.1371/journal.pone.0239883 33270643 PMC7714221 · DOI
- Hu C., Huang H., Na J., Lumby C., Abozaid M., Holdren M.A., Rao T.J., Karam R., Pesaran T., Weyandt J.D., Csuy C.M., Seelaus C.A., Young C.C., Fulk K., Heidari Z., Morais Lyra P.C., Couch R.E., Persons B., Polley E.C., Gnanaolivu R.D., Boddicker N.J., Monteiro A.N.A., Yadav S., Domchek S.M., Richardson M.E., Couch F.J., 2024. Functional analysis and clinical classification of 462 germline BRCA2 missense variants affecting the DNA binding domain. Am J Hum Genet 111, 584– 593. 10.1016/j.ajhg.2024.02.002 38417439 PMC10940015 · DOI
- Consortium IGVF, 2024. Deciphering the impact of genomic variation on function. Nature 633, 47– 57. 10.1038/s41586-024-07510-0 39232149 PMC11973978 · DOI
- Jia X., Burugula B.B., Chen V., Lemons R.M., Jayakody S., Maksutova M., Kitzman J.O., 2021. Massively parallel functional testing of MSH2 missense variants conferring Lynch syndrome risk. Am J Hum Genet 108, 163– 175. 10.1016/j.ajhg.2020.12.003 33357406 PMC7820803 · DOI
- Jiang C., Richardson E., Farr J., Hill A.P., Ullah R., Kroncke B.M., Harrison S.M., Thomson K.L., Ingles J., Vandenberg J.I., Ng C.-A., 2022. A calibrated functional patch-clamp assay to enhance clinical variant interpretation in KCNH2-related long QT syndrome. Am J Hum Genet 109, 1199– 1207. 10.1016/j.ajhg.2022.05.002 35688147 PMC9300752 · DOI
- Kato S., Han S.-Y., Liu W., Otsuka K., Shibata H., Kanamaru R., Ishioka C., 2003. Understanding the function–structure and function–mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. PNAS 100, 8424– 8429. 10.1073/pnas.1431692100 12826609 PMC166245 · DOI
- Kozek K.A., Glazer A.M., Ng C.-A., Blackwell D., Egly C.L., Vanags L.R., Blair M., Mitchell D., Matreyek K.A., Fowler D.M., Knollmann B.C., Vandenberg J.I., Roden D.M., Kroncke B.M., 2020. High-throughput discovery of trafficking-deficient variants in the cardiac potassium channel KV11.1. Heart Rhythm 17, 2180– 2189. 10.1016/j.hrthm.2020.05.041 32522694 PMC7704534 · DOI
- Landrum M.J., Chitipiralla S., Kaur K., Brown G., Chen C., Hart J., Hoffman D., Jang W., Liu C., Maddipatla Z., Maiti R., Mitchell J., Rezaie T., Riley G., Song G., Yang J., Ziyabari L., Russette A., Kattman B.L., 2025. ClinVar: updates to support classifications of both germline and somatic variants. Nucleic Acids Res 53, D1313– D1321. 10.1093/nar/gkae1090 39578691 PMC11701624 · DOI · Paper page
- Lee K., Abul-Husn N.S., Amendola L.M., Brothers K.B., Chung W.K., Gollob M.H., Gordon A.S., Harrison S.M., Hershberger R.E., Li M., Ondrasik D., Richards C.S., Stergachis A., Stewart D.R., Martin C.L., Miller D.T., ACMG Secondary Findings Working Group. Electronic address: documents@acmg.net, 2025. ACMG SF v3.3 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med 27, 101454. 10.1016/j.gim.2025.101454 40568962 PMC12318660 · DOI
- Lemaire B., Bauer F., Chaves Rodriguez E., Ghesquiere J., Radziejwoski A., Roth A., Boyer M., 2025. Web references are not eternal: time-trend and qualitative impact of the loss of access to online resources cited in peer-reviewed medical journals. Curr Med Res Opin 41, 543– 548. 10.1080/03007995.2025.2475091 40040548 · DOI
- Li C., Wilborn J., Pittman S., Daw J., Alonso-Pérez J., Díaz-Manera J., Weihl C.C., Haller G., 2023. Comprehensive functional characterization of SGCB coding variants predicts pathogenicity in limb-girdle muscular dystrophy type R4/2E. J Clin Invest 133, e168156. 10.1172/JCI168156 37317968 PMC10266784 · DOI
- Lo R.S., Cromie G.A., Tang M., Teng K., Owens K., Sirr A., Kutz J.N., Morizono H., Caldovic L., Ah Mew N., Gropman A., Dudley A.M., 2023. The functional impact of 1,570 individual amino acid substitutions in human OTC. Am J Hum Genet 110, 863– 879. 10.1016/j.ajhg.2023.03.019 37146589 PMC10183466 · DOI
- Ma J.G., O’Neill M.J., Richardson E., Thomson K.L., Ingles J., Muhammad A., Solus J.F., Davogustto G., Anderson K.C., Shoemaker M.B., Stergachis A.B., Floyd B.J., Dunn K., Parikh V.N., Chubb H., Perrin M.J., Roden D.M., Vandenberg J.I., Ng C.-A., Glazer A.M., 2024. Multisite Validation of a Functional Assay to Adjudicate SCN5A Brugada Syndrome-Associated Variants. Circ Genom Precis Med 17, e004569. 10.1161/CIRCGEN.124.004569 38953211 PMC11335442 · DOI
- Ma K., Huang S., Ng K.K., Lake N.J., Joseph S., Xu J., Lek A., Ge L., Woodman K.G., Koczwara K.E., Cohen J., Ho V., O’Connor C.L., Brindley M.A., Campbell K.P., Lek M., 2024. Saturation mutagenesis-reinforced functional assays for disease-related genes. Cell 187, 6707– 6724.e22. 10.1016/j.cell.2024.08.047 39326416 PMC11568926 · DOI
- Martin B.E., Sands T., Bier L., Bergner A., Boehme A.K., Lippa N., 2024. Comparing the frequency of variants of uncertain significance (VUS) between ancestry groups in a paediatric epilepsy cohort. J Med Genet 61, 645– 651. 10.1136/jmg-2023-109450 38453479 · DOI
- Matreyek K.A., Starita L.M., Stephany J.J., Martin B., Chiasson M.A., Gray V.E., Kircher M., Khechaduri A., Dines J.N., Hause R.J., Bhatia S., Evans W.E., Relling M.V., Yang W., Shendure J., Fowler D.M., 2018. Multiplex assessment of protein variant abundance by massively parallel sequencing. Nature Genetics 50, 874– 882. 10.1038/s41588-018-0122-z 29785012 PMC5980760 · DOI · Paper page
- McDonnell A.F., Plech M., Livesey B.J., Gerasimavicius L., Owen L.J., Hall H.N., FitzPatrick D.R., Marsh J.A., Kudla G., 2024. Deep mutational scanning quantifies DNA binding and predicts clinical outcomes of PAX6 variants. Mol Syst Biol 20, 825– 844. 10.1038/s44320-024-00043-8 38849565 PMC11219921 · DOI · Paper page
- McEwen A.E., Tejura M., Fayer S., Starita L.M., Fowler D.M., 2025. Multiplexed assays of variant effect for clinical variant interpretation. Nat Rev Genet. 10.1038/s41576-025-00870-x 40691352 · DOI
- Meitlis I., Allenspach E.J., Bauman B.M., Phan I.Q., Dabbah G., Schmitt E.G., Camp N.D., Torgerson T.R., Nickerson D.A., Bamshad M.J., Hagin D., Luthers C.R., Stinson J.R., Gray J., Lundgren I., Church J.A., Butte M.J., Jordan M.B., Aceves S.S., Schwartz D.M., Milner J.D., Schuval S., Skoda-Smith S., Cooper M.A., Starita L.M., Rawlings D.J., Snow A.L., James R.G., 2020. Multiplexed Functional Assessment of Genetic Variants in CARD11. Am J Hum Genet 107, 1029– 1043. 10.1016/j.ajhg.2020.10.015 33202260 PMC7820631 · DOI
- Mighell T.L., Evans-Dutson S., O’Roak B.J., 2018. A Saturation Mutagenesis Approach to Understanding PTEN Lipid Phosphatase Activity and Genotype-Phenotype Relationships. The American Journal of Human Genetics 102, 943– 955. 10.1016/j.ajhg.2018.03.018 29706350 PMC5986715 · DOI · Paper page
- Mighton C., Smith A.C., Mayers J., Tomaszewski R., Taylor S., Hume S., Agatep R., Spriggs E., Feilotter H.E., Semenuk L., Wong H., Lazo de la Vega L., Marshall C.R., Axford M.M., Silver T., Charames G.S., Di Gioacchino V., Watkins N., Foulkes W.D., Clavier M., Hamel N., Chong G., Lamont R.E., Parboosingh J., Karsan A., Bosdet I., Young S.S., Tucker, Akbari M.R., Speevak M.D., Vaags A.K., Lebo M.S., Lerner-Ellis J., Canadian Open Genetics Repository Working Group, 2022. Data sharing to improve concordance in variant interpretation across laboratories: results from the Canadian Open Genetics Repository. J Med Genet 59, 571– 578. 10.1136/jmedgenet-2021-107738 33875564 PMC8523590 · DOI
- Muhammad A., Calandranis M.E., Li B., Yang T., Blackwell D.J., Harvey M.L., Smith J.E., Daniel Z.A., Chew A.E., Capra J.A., Matreyek K.A., Fowler D.M., Roden D.M., Glazer A.M., 2024. High-throughput functional mapping of variants in an arrhythmia gene, KCNE1, reveals novel biology. Genome Med 16, 73. 10.1186/s13073-024-01340-5 38816749 PMC11138074 · DOI
- Ndugga-Kabuye M.K., Issaka R.B., 2019. Inequities in multi-gene hereditary cancer testing: lower diagnostic yield and higher VUS rate in individuals who identify as Hispanic, African or Asian and Pacific Islander as compared to European. Fam Cancer 18, 465– 469. 10.1007/s10689-019-00144-6 31531760 PMC6785397 · DOI
- Olvera-León R., Zhang F., Offord V., Zhao Y., Tan H.K., Gupta P., Pal T., Robles-Espinoza C.D., Arriaga-González F.G., Matsuyama L.S.A.S., Delage E., Dicks E., Ezquina S., Rowlands C.F., Turnbull C., Pharoah P., Perry J.R.B., Jasin M., Waters A.J., Adams D.J., 2024. High-resolution functional mapping of RAD51C by saturation genome editing. Cell 187, 5719– 5734.e19. 10.1016/j.cell.2024.08.039 39299233 PMC12147941 · DOI · Paper page
- O’Neill M.J., Ng C.-A., Aizawa T., Sala L., Bains S., Winbo A., Ullah R., Shen Q., Tan C.-Y., Kozek K., Vanags L.R., Mitchell D.W., Shen A., Wada Y., Kashiwa A., Crotti L., Dagradi F., Musu G., Spazzolini C., Neves R., Bos J.M., Giudicessi J.R., Bledsoe X., Gamazon E.R., Lancaster M.C., Glazer A.M., Knollmann B.C., Roden D.M., Weile J., Roth F., Salem J.-E., Earle N., Stiles R., Agee T., Johnson C.N., Horie M., Skinner J.R., Ackerman M.J., Schwartz P.J., Ohno S., Vandenberg J.I., Kroncke B.M., 2024. Multiplexed Assays of Variant Effect and Automated Patch Clamping Improve KCNH2-LQTS Variant Classification and Cardiac Event Risk Stratification. Circulation 150, 1869– 1881. 10.1161/CIRCULATIONAHA.124.069828 39315434 PMC11611689 · DOI
- Park M.S., Kumar R.D., Ovadiuc C., Folta A., McEwen A.E., Snyder A., Villani R.M., Spurdle A.B., Fowler D.M., Rubin A.F., Shirts B.H., Starita L.M., Stergachis A.B., 2025. Insights on improving accessibility and usability of functional data to unlock their potential for variant interpretation. Am J Hum Genet 112, 1468– 1478. 10.1016/j.ajhg.2025.04.009 40480199 PMC12256793 · DOI
- Pawliczek P., Patel R.Y., Ashmore L.R., Jackson A.R., Bizon C., Nelson T., Powell B., Freimuth R.R., Strande N., Shah N., Paithankar S., Wright M.W., Dwight S., Zhen J., Landrum M., McGarvey P., Babb L., Plon S.E., Milosavljevic A., Clinical Genome (ClinGen) Resource, 2018. ClinGen Allele Registry links information about genetic variants. Hum Mutat 39, 1690– 1701. 10.1002/humu.23637 30311374 PMC6519371 · DOI
- Popp N.A., Powell R.L., Wheelock M.K., Holmes K.J., Zapp B.D., Sheldon K.M., Fletcher S.N., Wu X., Fayer S., Rubin A.F., Lannert K.W., Chang A.T., Sheehan J.P., Johnsen J.M., Fowler D.M., 2025. Multiplex and multimodal mapping of variant effects in secreted proteins via MultiSTEP. Nat Struct Mol Biol. 10.1038/s41594-025-01582-w PMC12373428 40514537 · DOI · Paper page
- Radford E.J., Tan H.-K., Andersson M.H.L., Stephenson J.D., Gardner E.J., Ironfield H., Waters A.J., Gitterman D., Lindsay S., Abascal F., Martincorena I., Kolesnik-Taylor A., Ng-Cordell E., Firth H.V., Baker K., Perry J.R.B., Adams D.J., Gerety S.S., Hurles M.E., 2023. Saturation genome editing of DDX3X clarifies pathogenicity of germline and somatic variation. Nat Commun 14, 7702. 10.1038/s41467-023-43041-4 38057330 PMC10700591 · DOI
- Rehm H.L., Alaimo J.T., Aradhya S., Bayrak-Toydemir P., Best H., Brandon R., Buchan J.G., Chao E.C., Chen E., Clifford J., Cohen A.S.A., Conlin L.K., Das S., Davis K.W., Del Gaudio D., Del Viso F., DiVincenzo C., Eisenberg M., Guidugli L., Hammer M.B., Harrison S.M., Hatchell K.E., Dyer L.H., Hoang L.U., Holt J.M., Jobanputra V., Karbassi I.D., Kearney H.M., Kelly M.A., Kelly J.M., Kluge M.L., Komala T., Kruszka P., Lau L., Lebo M.S., Marshall C.R., McKnight D., McWalter K., Meng Y., Nagan N., Neckelmann C.S., Neerman N., Niu Z., Paolillo V.K., Paolucci S.A., Perry D., Pesaran T., Radtke K., Rasmussen K.J., Retterer K., Saunders C.J., Spiteri E., Stanley C., Szuto A., Taft R.J., Thiffault I., Thomas B.C., Thomas-Wilson A., Thorpe E., Tidwell T.J., Towne M.C., Zouk H., Medical Genome Initiative Steering Committee, 2023. The landscape of reported VUS in multi-gene panel and genomic testing: Time for a change. Genet Med 25, 100947. 10.1016/j.gim.2023.100947 37534744 PMC10825061 · DOI
- Rehm H.L., Page A.J.H., Smith L., Adams J.B., Alterovitz G., Babb L.J., Barkley M.P., Baudis M., Beauvais M.J.S., Beck T., Beckmann J.S., Beltran S., Bernick D., Bernier A., Bonfield J.K., Boughtwood T.F., Bourque G., Bowers S.R., Brookes A.J., Brudno M., Brush M.H., Bujold D., Burdett T., Buske O.J., Cabili M.N., Cameron D.L., Carroll R.J., Casas-Silva E., Chakravarty D., Chaudhari B.P., Chen S.H., Cherry J.M., Chung J., Cline M., Clissold H.L., Cook-Deegan R.M., Courtot M., Cunningham F., Cupak M., Davies R.M., Denisko D., Doerr M.J., Dolman L.I., Dove E.S., Dursi L.J., Dyke S.O.M., Eddy J.A., Eilbeck K., Ellrott K.P., Fairley S., Fakhro K.A., Firth H.V., Fitzsimons M.S., Fiume M., Flicek P., Fore I.M., Freeberg M.A., Freimuth R.R., Fromont L.A., Fuerth J., Gaff C.L., Gan W., Ghanaim E.M., Glazer D., Green R.C., Griffith M., Griffith O.L., Grossman R.L., Groza T., Auvil J.M.G., Guigó R., Gupta D., Haendel M.A., Hamosh A., Hansen D.P., Hart R.K., Hartley D.M., Haussler D., Hendricks-Sturrup R.M., Ho C.W.L., Hobb A.E., Hoffman M.M., Hofmann O.M., Holub P., Hsu J.S., Hubaux J.-P., Hunt S.E., Husami A., Jacobsen J.O., Jamuar S.S., Janes E.L., Jeanson F., Jené A., Johns A.L., Joly Y., Jones S.J.M., Kanitz A., Kato K., Keane T.M., Kekesi-Lafrance K., Kelleher J., Kerry G., Khor S.-S., Knoppers B.M., Konopko M.A., Kosaki K., Kuba M., Lawson J., Leinonen R., Li S., Lin M.F., Linden M., Liu X., Udara Liyanage I., Lopez J., Lucassen A.M., Lukowski M., Mann A.L., Marshall J., Mattioni M., Metke-Jimenez A., Middleton A., Milne R.J., Molnár-Gábor F., Mulder N., Munoz-Torres M.C., Nag R., Nakagawa H., Nasir J., Navarro A., Nelson T.H., Niewielska A., Nisselle A., Niu J., Nyrönen T.H., O’Connor B.D., Oesterle S., Ogishima S., Wang V.O., Paglione L.A.D., Palumbo E., Parkinson H.E., Philippakis A.A., Pizarro A.D., Prlic A., Rambla J., Rendon A., Rider R.A., Robinson P.N., Rodarmer K.W., Rodriguez L.L., Rubin A.F., Rueda M., Rushton G.A., Ryan R.S., Saunders G.I., Schuilenburg H., Schwede T., Scollen S., Senf A., Sheffield N.C., Skantharajah N., Smith A.V., Sofia H.J., Spalding D., Spurdle A.B., Stark Z., Stein L.D., Suematsu M., Tan P., Tedds J.A., Thomson A.A., Thorogood A., Tickle T.L., Tokunaga K., Törnroos J., Torrents D., Upchurch S., Valencia A., Guimera R.V., Vamathevan J., Varma S., Vears D.F., Viner C., Voisin C., Wagner A.H., Wallace S.E., Walsh B.P., Williams M.S., Winkler E.C., Wold B.J., Wood G.M., Woolley J.P., Yamasaki C., Yates A.D., Yung C.K., Zass L.J., Zaytseva K., Zhang J., Goodhand P., North K., Birney E., 2021. GA4GH: International policies and standards for data sharing across genomic research and healthcare. Cell Genom 1, 100029. 10.1016/j.xgen.2021.100029 35072136 PMC8774288 · DOI
- Rubin A.F., Stone J., Bianchi A.H., Capodanno B.J., Da E.Y., Dias M., Esposito D., Frazer J., Fu Y., Grindstaff S.B., Harrington M.R., Li I., McEwen A.E., Min J.K., Moore N., Moscatelli O.G., Ong J., Polunina P.V., Rollins J.E., Rollins N.J., Snyder A.E., Tam A., Wakefield M.J., Ye S.S., Starita L.M., Bryant V.L., Marks D.S., Fowler D.M., 2025. MaveDB 2024: a curated community database with over seven million variant effects from multiplexed functional assays. Genome Biol 26, 13. 10.1186/s13059-025-03476-y 39838450 PMC11753097 · DOI · Paper page
- Sahu S., Galloux M., Southon E., Caylor D., Sullivan T., Arnaudi M., Zanti M., Geh J., Chari R., Michailidou K., Papaleo E., Sharan S.K., 2025. Saturation genome editing-based clinical classification of BRCA2 variants. Nature 638, 538– 545. 10.1038/s41586-024-08349-1 39779848 · DOI
- Sahu S., Sullivan T.L., Mitrophanov A.Y., Galloux M., Nousome D., Southon E., Caylor D., Mishra A.P., Evans C.N., Clapp M.E., Burkett S., Malys T., Chari R., Biswas K., Sharan S.K., 2023. Saturation genome editing of 11 codons and exon 13 of BRCA2 coupled with chemotherapeutic drug response accurately determines pathogenicity of variants. PLoS Genet 19, e1010940. 10.1371/journal.pgen.1010940 37713444 PMC10529611 · DOI
- Shepherdson J.L., Granas D.M., Li J., Shariff Z., Plassmeyer S.P., Holehouse A.S., White M.A., Cohen B.A., 2024. Mutational scanning of CRX classifies clinical variants and reveals biochemical properties of the transcriptional effector domain. Genome Res 34, 1540– 1552. 10.1101/gr.279415.124 39322280 PMC11529990 · DOI
- Starita L.M., Ahituv N., Dunham M.J., Kitzman J.O., Roth F.P., Seelig G., Shendure J., Fowler D.M., 2017. Variant Interpretation: Functional Assays to the Rescue. The American Journal of Human Genetics 101, 315– 325. 10.1016/j.ajhg.2017.07.014 28886340 PMC5590843 · DOI · Paper page
- Sun S., Weile J., Verby M., Wu Y., Wang Y., Cote A.G., Fotiadou I., Kitaygorodsky J., Vidal M., Rine J., Ješina P., Kožich V., Roth F.P., 2020. A proactive genotype-to-patient-phenotype map for cystathionine beta-synthase. Genome Medicine 12, 13. 10.1186/s13073-020-0711-1 32000841 PMC6993387 · DOI
- Sung A.Y., Guerra R.M., Steenberge L.H., Alston C.L., Murayama K., Okazaki Y., Shimura M., Prokisch H., Ghezzi D., Torraco A., Carrozzo R., Rötig A., Taylor R.W., Keck J.L., Pagliarini D.J., 2024. Systematic analysis of NDUFAF6 in complex I assembly and mitochondrial disease. Nat Metab 6, 1128– 1142. 10.1038/s42255-024-01039-2 38720117 PMC11395703 · DOI
- Tabet D., Parikh V., Mali P., Roth F.P., Claussnitzer M., 2022. Scalable Functional Assays for the Interpretation of Human Genetic Variation. Annu Rev Genet 56, 441– 465. 10.1146/annurev-genet-072920-032107 36055970 · DOI
- Tavtigian S.V., Greenblatt M.S., Harrison S.M., Nussbaum R.L., Prabhu S.A., Boucher K.M., Biesecker L.G., ClinGen Sequence Variant Interpretation Working Group (ClinGen SVI), 2018. Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework. Genet Med 20, 1054– 1060. 10.1038/gim.2017.210 29300386 PMC6336098 · DOI · Paper page
- van Loggerenberg W., Sowlati-Hashjin S., Weile J., Hamilton R., Chawla A., Sheykhkarimli D., Gebbia M., Kishore N., Frésard L., Mustajoki S., Pischik E., Di Pierro E., Barbaro M., Floderus Y., Schmitt C., Gouya L., Colavin A., Nussbaum R., Friesema E.C.H., Kauppinen R., To-Figueras J., Aarsand A.K., Desnick R.J., Garton M., Roth F.P., 2023. Systematically testing human HMBS missense variants to reveal mechanism and pathogenic variation. Am J Hum Genet 110, 1769– 1786. 10.1016/j.ajhg.2023.08.012 37729906 PMC10577081 · DOI
- Villani R.M., Terrill B., Tudini E., McKenzie M.E., Cliffe C.C., Hahn C.N., Lundie B., Mattiske T., Matotek E., McEwen A.E., Nickerson S.L., Breen J., Fowler D.M., Christodoulou J., Starita L., Rubin A.F., Spurdle A.B., 2025. Consultation informs strategies for improving the use of functional evidence in variant classification. Am J Hum Genet 112, 1489– 1495. 10.1016/j.ajhg.2025.05.003 40480201 PMC12256917 · DOI
- Wagner A.H., Babb L., Alterovitz G., Baudis M., Brush M., Cameron D.L., Cline M., Griffith M., Griffith O.L., Hunt S.E., Kreda D., Lee J.M., Li S., Lopez J., Moyer E., Nelson T., Patel R.Y., Riehle K., Robinson P.N., Rynearson S., Schuilenburg H., Tsukanov K., Walsh B., Konopko M., Rehm H.L., Yates A.D., Freimuth R.R., Hart R.K., 2021. The GA4GH Variation Representation Specification: A computational framework for variation representation and federated identification. Cell Genom 1, 100027. 10.1016/j.xgen.2021.100027 35311178 PMC8929418 · DOI
- Wan A., Place E., Pierce E.A., Comander J., 2019. Characterizing variants of unknown significance in rhodopsin: A functional genomics approach. Hum Mutat 40, 1127– 1144. 10.1002/humu.23762 30977563 PMC7027811 · DOI
- Waters A.J., Brendler-Spaeth T., Smith D., Offord V., Tan H.K., Zhao Y., Obolenski S., Nielsen M., van Doorn R., Murphy J.-E., Gupta P., Rowlands C.F., Hanson H., Delage E., Thomas M., Radford E.J., Gerety S.S., Turnbull C., Perry J.R.B., Hurles M.E., Adams D.J., 2024. Saturation genome editing of BAP1 functionally classifies somatic and germline variants. Nat Genet 56, 1434– 1445. 10.1038/s41588-024-01799-3 38969833 PMC11250367 · DOI
- Weile J., Roth F.P., 2018. Multiplexed assays of variant effects contribute to a growing genotype-phenotype atlas. Hum Genet 137, 665– 678. 10.1007/s00439-018-1916-x 30073413 PMC6153521 · DOI
- Weile J., Sun S., Cote A.G., Knapp J., Verby M., Mellor J.C., Wu Y., Pons C., Wong C., Lieshout N. van, Yang F., Tasan M., Tan G., Yang S., Fowler D.M., Nussbaum R., Bloom J.D., Vidal M., Hill D.E., Aloy P., Roth F.P., 2017. A framework for exhaustively mapping functional missense variants. Molecular Systems Biology 13, 957. 10.15252/msb.20177908 29269382 PMC5740498 · DOI · Paper page
- Zeiberg D., Tejura M., McEwen A.E., Fayer S., Pejaver V., Rubin A.F., Starita L.M., Fowler D.M., O’Donnell-Luria A., Radivojac P., 2025. Gene-based calibration of high-throughput functional assays for clinical variant classification. bioRxiv 2025.04.29.651326. 10.1101/2025.04.29.651326 · DOI
- Zheng H., Yan X., Li G., Lin H., Deng S., Zhuang W., Yao F., Lu Y., Xia X., Yuan H., Jin L., Yan Z., 2022. Proactive functional classification of all possible missense single-nucleotide variants in KCNQ4. Genome Res 32, 1573– 1584. 10.1101/gr.276562.122 35760561 PMC9435748 · DOI
Cited by
Sorted by citations
Massively parallel functional genomic assays in endocrinology: from promise to delivery
Xu, J., Aslanzadeh, V., Kudla, G., & Semple, R. K. (2026) · Journal of Molecular Endocrinology · doi:10.1530/jme-25-0134
- Authors
- McEwen, A. E., Stone, J., Tejura, M., Gupta, P., Capodanno, B. J., Da, E. Y., Grindstaff, S. B., Moore, N., Reinhart, D., Snyder, A. E., Stergachis, A. B., Starita, L. M., Fowler, D. M., & Rubin, A. F.
- Affiliations
- University of Washington (US)
- Walter and Eliza Hall Institute of Medical Research (AU)
- The University of Melbourne (AU)
- Corresponding author
- Rubin, Alan F.
- ORCID
- Venue
- Genome Medicine
- Publisher
- openRxiv
- Published
- 2025-11-19
- ISSN
- 1756-994X (ISSN-L)
- PMC
- PMC12668102
- OpenAlex
- W7214729282
- Cited by
- 5
- References
- 1
- Citations by year
- 2026: 5
- FWCI
- 16.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Genome Medicine (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Burroughs Wellcome Fund
- Pew Charitable Trusts
- Alex's Lemonade Stand Foundation for Childhood Cancer
- Warren Alpert Foundation (WAF-CLEP- PD 10089501-01)
- National Institutes of Health
- National Human Genome Research Institute (UM1HG011969, R01HG013025)
- Medical Research Future Fund
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- variants of uncertain significance, MAVE, MaveDB, variant effect prediction, clinical variant interpretation, genomic medicine, disease-associated genes, variant interpretation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review